|
ZNF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.857300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.875500E-03 |
| Normal-vs-Stage2 |
8.404400E-03 |
| Normal-vs-Stage3 |
1.540430E-02 |
| Normal-vs-Stage4 |
2.309600E-01 |
| Stage1-vs-Stage2 |
3.055200E-01 |
| Stage1-vs-Stage3 |
8.548400E-01 |
| Stage1-vs-Stage4 |
3.796400E-01 |
| Stage2-vs-Stage3 |
4.724600E-01 |
| Stage2-vs-Stage4 |
1.831250E-01 |
| Stage3-vs-Stage4 |
3.560600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.599820E-02 |
| Normal-vs-AfricanAmerican |
4.304200E-01 |
| Normal-vs-Asian |
2.262000E-01 |
| Caucasian-vs-AfricanAmerican |
3.822600E-01 |
| Caucasian-vs-Asian |
2.624200E-01 |
| AfricanAmerican-vs-Asian |
8.535000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.833230E-01 |
| Normal-vs-Female |
1.279260E-03 |
| Male-vs-Female |
2.378300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.497580E-02 |
| Normal-vs-Age(41-60Yrs) |
5.138000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.534400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.853600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.869000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.155400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.050400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.122000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.473000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.554000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.020800E-03 |
| Classical-VS-Follicular |
3.838100E-04 |
| Classical-VS-Other |
6.587000E-01 |
| Classical-VS-Normal |
1.186780E-01 |
| Tall-VS-Follicular |
9.142000E-01 |
| Tall-VS-Other |
3.044000E-01 |
| Tall-VS-Normal |
8.039600E-04 |
| Follicular-VS-Other |
4.389600E-01 |
| Follicular-VS-Normal |
2.841500E-04 |
| Other-VS-Normal |
3.270200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.376600E-04 |
| Normal-vs-N1 |
2.441400E-01 |
| N0-vs-N1 |
8.655900E-02 |
|
|
